EWA
KYNB

EverSource Wealth Advisors’s Kyntra Bio KYNB Stock Holding History

EverSource Wealth Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29
Closed -$389 – 4077
2024
Q4 		$389 Hold
29
– – ﹤0.01% 3273
2024
Q3 		$293 Hold
29
– – ﹤0.01% 2933
2024
Q2 		$396 Hold
29
– – ﹤0.01% 2935
2024
Q1 		$822 Hold
29
– – ﹤0.01% 2631
2023
Q4 		$651 Buy
+29
New +$437 ﹤0.01% 2474

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EverSource Wealth Advisors's KYNB Position: Q1 2025 in Review

EverSource Wealth Advisors sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 29 shares — an estimated $389 sold.

EverSource Wealth Advisors first reported a position in KYNB in Q4 2023 and held it in 5 quarters. The position peaked at $822 in Q1 2024. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • EverSource Wealth Advisors reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 29 Kyntra Bio shares in Q1 2025, an estimated $389.
  • EverSource Wealth Advisors first reported a position in Kyntra Bio in Q4 2023 and held it in 5 quarters.
  • EverSource Wealth Advisors's Kyntra Bio position peaked at $822 in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on EverSource Wealth Advisors's 13F filing for Q1 2025, filed 13 May 2025.